Successful use of tissue plasminogen activator (t-PA) in catheter- related intracardiac thrombi of two premature infants

Acta Paediatrica, International Journal of Paediatrics

Volumn 87, Issue 6, 1998, Pages 695-698

  Giuffre B ^a   Compagnoni, G ^a   Farina, C ^a   Mosca, F ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Catheter; Intracardiac thrombus; Preterm infants; Tissue plasminogen activator

Indexed keywords

FRESH FROZEN PLASMA; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; CENTRAL VENOUS CATHETER; DRUG EFFECT; HUMAN; INTRACARDIAC THROMBOSIS; INTRAUTERINE GROWTH RETARDATION; MALE; NEWBORN; PARENTERAL NUTRITION; PREMATURITY; PRIORITY JOURNAL; THROMBUS; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

CATHETERIZATION, CENTRAL VENOUS; DISEASE-FREE SURVIVAL; DISEASES IN TWINS; ECHOCARDIOGRAPHY; FATAL OUTCOME; FETAL DISTRESS; FETAL GROWTH RETARDATION; HEART DISEASES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PLASMINOGEN ACTIVATORS; THROMBOLYTIC THERAPY; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0031822710     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/080352598750014148     Document Type: Article

References (18)

1. Lumb PD. Complications of central venous catheters. Crit Care Med 1993; 21: 1105-6
2. Schmidt B, Zipensky A. Thrombotic disease in newborn infants. Clin Perinatol 1984; 11: 461-88
3. Van Overmeire B, Van Reempts PJ, Van Acker KJ. Intracardiac thrombus formation with rapidly progressive heart failure in the neonate: treatment with tissue type plasminogen activator. Arch Dis Child 1992; 67: 443-5
4. Delaplane D, Scott JP, Riggs TW, Silverman BL, Hunt CE. Urokinase therapy for a catheter-related right atrial thrombus. J Pediatr 1982; 100: 149-52
5. Kennedy CA, Drummond WH, Knight ME, et al. Successful treatment of neonatal aortic thrombosis with tissue plasminogen activator. J Pediatr 1990; 116: 798-801
6. Levy M, Benson LN, Burrons PE, et al. Tissue plasminogen activator tor the treatment of thromboemholism in infants and children. J Pediatr 1991: 118: 467-72
7. Dillon PW, Fox PS, Berg CJ, et al. Recombinant tissue plasminogen activator for neonatal and pediatric vascular thrombolytic therapy. J Pediatr Surg 1993; 28: 1264-8.
8. Novak Gottl U, Kreuz WD, Schwabe D, et al. Thrombolysis with rt-PA in children with arterial and venous thromboses: new therapy concept. Klin Padiatr 1991; 203: 359-62
9. Andersen BJ, Keeley SR, Johnson ND, et al. Caval thrombolysis in neonates using low doses of recombinant human tissue-type plasminogen activator. Anaesth Intens Care 1991; 19: 22-7
10. Nikhil C, Gonzalez RE, Bhat AM. Umbilical venous catheters (UVC): evaluation of radiographs to determine position and associated complications of malpositioned UVCs. Pediatr Res 1994; 35: 250A
11. Caccamo ML, Rossi E, Salmoiraghi MG, Mondonico P, Gianotti GA, Marini A. The fibrinolytic system in the newborn: role of histidine-rich glycoprotein. Biol Neonate 1992; 61: 281-4
12. Andrew M. Development of the haemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990; 12: 95-104
13. Perry LS, Tresch DD, Brooks HL, et al. Operative approach to endocarditis. Am Heart J 1984; 108: 561-6
14. Marder VJ, Sherry S. Thrombolytic therapy: current status. N Engl J Med 1988; 318: 1512-95
15. Wever MLG, Liem KD, Geven WB, Tanke RB. Urokinase therapy in neonates with catheter related central venous thrombosis. Thromb Haemost 1995; 73: 180-5
16. Crabbe SJ, Cloninger CC. Tissue plasminogen activator: a new thrombolytic agent. Clin Pharmacol 1987; 6: 373-86
17. Andrew M, Brooker L, Leaker M, Paies B, Weitz J. Fibrin clotlysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration. Thromb Haemost 1992; 68,3: 325-30
18. Doyle H, Britto J, Freeman J, Munro F, Murton NS. Thrombolysis with low dose tissue plasminogen activator. Arch Dis Child 1992; 67: 1483-5